RaQualia Pharma Inc. (4579.T)
JPY 337.0
(0.9%)
JPY 337.0
(0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -718.59 Million | 1.48 Billion | 366.02 Million | -289.2 Million | -530.84 Million | -403.99 Million |
| Net Income | -323.66 Million | 851.01 Million | 880.57 Million | -527.94 Million | 27.31 Million | -1.07 Billion |
| Depreciation & Amortization | 175.56 Million | 147.73 Million | 141.55 Million | 124.25 Million | 140.05 Million | 125.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -460.31 Million | 677.22 Million | -459.6 Million | 132.82 Million | -717.78 Million | 599.24 Million |
| Other non-cash items | -110.18 Million | -195.87 Million | -196.5 Million | -18.34 Million | 19.57 Million | -50.63 Million |
| Investing Cash Flow | -135.37 Million | -47.64 Million | -279.25 Million | 225.47 Million | 216.2 Million | -368.05 Million |
| Investments in PPE | -222.2 Million | -31.9 Million | -105.41 Million | -156.35 Million | -94.37 Million | -221.13 Million |
| Acquisitions | - | - | -13.92 Million | -5.44 Million | - | 7.79 Million |
| Investment purchases | -260 Million | -951.63 Million | -718.15 Million | -106.93 Million | - | -785.27 Million |
| Sales/Maturities of investments | 350 Million | 935.89 Million | 543.82 Million | 487.82 Million | 311.44 Million | 640.35 Million |
| Other Investing Activities | -3.16 Million | -1000.00 | 14.42 Million | 6.38 Million | -859 Thousand | -9.79 Million |
| Financing Cash Flow | 793.45 Million | -29.56 Million | -16.44 Million | -6.96 Million | 695.9 Million | 99.18 Million |
| Debt repayment | -12.47 Million | -1.31 Million | -10 Million | -7.37 Million | -741 Thousand | -555 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 805.92 Million | 4.03 Million | 1.85 Million | 409 Thousand | 692.23 Million | 99.74 Million |
| Other Financing Activities | 19.36 Million | -32.28 Million | -8.29 Million | -6 Million | 4.41 Million | -556 Thousand |
| Accounts receivables | -92.32 Million | 579.23 Million | -598.69 Million | 160.9 Million | -751.38 Million | 434.25 Million |
| Accounts payables | -73.89 Million | 82.07 Million | 4.16 Million | 7.53 Million | 34.29 Million | -1.98 Million |
| Inventory | -139.43 Million | 2.04 Million | -4 Million | -1.04 Million | 998 Thousand | -1.34 Million |
| Other working capital | -154.65 Million | 13.86 Million | 138.93 Million | -34.57 Million | -1.69 Million | 600.59 Million |
| Cash at beginning of period | 3.92 Billion | 2.24 Billion | 2.06 Billion | 2.2 Billion | 1.82 Billion | 2.47 Billion |
| Cash at end of period | 3.76 Billion | 3.67 Billion | 2.24 Billion | 2.06 Billion | 2.2 Billion | 1.82 Billion |
| Capital Expenditure | -222.2 Million | -31.9 Million | -105.41 Million | -156.35 Million | -94.37 Million | -221.13 Million |
| Effect of forex changes on cash | 45.95 Million | 35.77 Million | 109.01 Million | -68.19 Million | -10.59 Million | 28.49 Million |
| Net cash flow / Change in cash | -161.31 Million | 1.43 Billion | 179.34 Million | -138.89 Million | 370.66 Million | -644.37 Million |
| Free Cash Flow | -940.8 Million | 1.44 Billion | 260.6 Million | -445.55 Million | -625.22 Million | -625.13 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -245.75 Million | -78.1 Million | -323.66 Million | -206.02 Million | -73.82 Million | 146.73 Million |
| Depreciation & Amortization | 46.42 Million | 45.14 Million | 175.56 Million | 55.05 Million | 48.78 Million | 40.74 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 373.25 Million | -490.76 Million | -460.31 Million | -136.97 Million | 410.76 Million | -665.39 Million |
| Other non-cash items | -225.08 Million | 680.54 Million | -110.18 Million | -25.54 Million | -75.48 Million | -26.75 Million |
| Investing Cash Flow | 76.79 Million | -3.74 Billion | -135.37 Million | 133.39 Million | 26.79 Million | -261.98 Million |
| Investments in PPE | -19.57 Million | -20.53 Million | -222.2 Million | -16.02 Million | -70.61 Million | -101.98 Million |
| Acquisitions | - | -3.87 Billion | - | - | -1.15 Million | - |
| Investment purchases | - | - | -260 Million | - | -100 Million | -160 Million |
| Sales/Maturities of investments | 102.56 Million | 155.99 Million | 350 Million | 150 Million | 200 Million | - |
| Other Investing Activities | -6.2 Million | -2.61 Million | -3.16 Million | -576 Thousand | -1.43 Million | -169 Million |
| Financing Cash Flow | -346.77 Million | 3.54 Billion | 793.45 Million | -18.99 Million | -14.09 Million | -14.01 Million |
| Debt repayment | -346.75 Million | -3.54 Billion | -12.47 Million | -22.76 Million | -3.15 Million | -3.15 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -16 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | - | 805.92 Million | 3.76 Million | - | - |
| Other Financing Activities | -1000.00 | -1000.00 | 19.36 Million | -1000.00 | -10.94 Million | -10.85 Million |
| Accounts receivables | 430.71 Million | -487.21 Million | -92.32 Million | -225.92 Million | 357.52 Million | -399.37 Million |
| Accounts payables | -518 Thousand | 9.01 Million | -73.89 Million | -17.3 Million | 3.12 Million | 6.73 Million |
| Inventory | -5.37 Million | 1.47 Million | -139.43 Million | -140.18 Million | 611 Thousand | 201 Thousand |
| Other working capital | -51.04 Million | -14.04 Million | -154.65 Million | 246.44 Million | 49.5 Million | -272.95 Million |
| Cash at beginning of period | 3.17 Billion | 3.76 Billion | 3.92 Billion | 3.99 Billion | 3.56 Billion | 4.28 Billion |
| Cash at end of period | 3.08 Billion | 3.17 Billion | 3.76 Billion | 3.76 Billion | 3.91 Billion | 3.56 Billion |
| Capital Expenditure | -19.57 Million | -20.53 Million | -222.2 Million | -16.02 Million | -70.61 Million | -101.98 Million |
| Effect of forex changes on cash | 24.06 Million | 30.7 Million | 45.95 Million | -52.07 Million | 27.23 Million | 64.03 Million |
| Net cash flow / Change in cash | -98.69 Million | -585.43 Million | -161.31 Million | -230.14 Million | 350.16 Million | -716.62 Million |
| Free Cash Flow | 261.25 Million | -430.72 Million | -940.8 Million | -329.51 Million | 239.62 Million | -606.64 Million |
IMOS
DWARKESH
4733
NVT
LNG
0HOT